CAS 2227425-05-8

PF-06869206

CAS : 2227425-05-8

Formule : C₁₅H₁₄ClF₃N₄O₂

Degré de pureté : 99%

Masse moléculaire : 374.7455

Ref: IN-DA01EOI0

PF-06869206

CAS : 2227425-05-8

PF-06869206

Degré de pureté : ≥98%

Masse moléculaire : 374.75g/mol

Ref: 54-BUP14274

PF-06869206

CAS : 2227425-05-8

PF-06869206 is an oral selective inhibitor of the sodium-phosphate cotransporter NaPi2a (SLC34A1, IC50: 380 nM).

Formule : C₁₅H₁₄ClF₃N₄O₂

Degré de pureté : 99.79% - 99.88%

Couleur et forme : Solid

Masse moléculaire : 374.75

Ref: TM-TQ0011

PF-06869206

CAS : 2227425-05-8

PF-06869206 is a binder that binds to the parathyroid hormone receptor and inhibits its activity. It is used for the treatment of chronic kidney disease, where it reduces urinary flow rate and inhibits growth factor production, thereby reducing bone loss. PF-06869206 has been shown to lower blood calcium levels in wild-type mice with high-calcium diets, but does not affect the calcium levels of wild-type mice with low-calcium diets. This drug also inhibits parathyroid hormone secretion and decreases renal excretion of phosphate and chloride in vivo studies.
PF-06869206 is orally bioavailable and can be given both once or twice daily. In vivo studies have shown that this drug has nonselective binding properties as it binds to both active and inactive forms of the parathyroid hormone receptor.br>

Formule : C₁₅H₁₄ClF₃N₄O₂

Degré de pureté : Min. 95%

Masse moléculaire : 374.75 g/mol

Ref: 3D-CPD42505